Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BLRX |
---|---|---|
09:32 ET | 6892 | 0.659 |
09:38 ET | 10281 | 0.6406 |
09:41 ET | 502 | 0.646 |
09:43 ET | 2600 | 0.6417 |
09:45 ET | 100 | 0.65 |
09:48 ET | 2196 | 0.6476 |
09:50 ET | 267 | 0.65 |
10:01 ET | 642 | 0.65 |
10:10 ET | 5800 | 0.6452 |
10:12 ET | 29078 | 0.64 |
10:15 ET | 250 | 0.645 |
10:19 ET | 8900 | 0.64 |
10:28 ET | 180 | 0.640761 |
10:30 ET | 100 | 0.64 |
10:33 ET | 100 | 0.6498 |
10:37 ET | 1500 | 0.644899 |
10:39 ET | 2000 | 0.64 |
10:44 ET | 1300 | 0.6449 |
10:46 ET | 2600 | 0.6497 |
10:50 ET | 1700 | 0.64 |
11:02 ET | 1700 | 0.64 |
11:26 ET | 100 | 0.6447 |
11:31 ET | 650 | 0.6402 |
11:38 ET | 500 | 0.649299 |
11:40 ET | 485 | 0.6402 |
11:42 ET | 100 | 0.64 |
12:21 ET | 5300 | 0.641 |
12:25 ET | 900 | 0.6485 |
12:27 ET | 312 | 0.6488 |
12:30 ET | 300 | 0.6489 |
12:36 ET | 5000 | 0.6488 |
12:59 ET | 135 | 0.641001 |
01:01 ET | 100 | 0.6486 |
01:17 ET | 1300 | 0.641 |
01:26 ET | 100 | 0.648399 |
01:32 ET | 2950 | 0.6405 |
01:37 ET | 3248 | 0.6409 |
01:39 ET | 300 | 0.6396 |
01:44 ET | 150 | 0.6402 |
01:48 ET | 12923 | 0.6409 |
02:02 ET | 100 | 0.6409 |
02:15 ET | 2222 | 0.635 |
02:18 ET | 200 | 0.6334 |
02:24 ET | 10050 | 0.631 |
02:26 ET | 4000 | 0.6309 |
02:27 ET | 6300 | 0.63 |
02:29 ET | 4650 | 0.63 |
02:31 ET | 5900 | 0.6307 |
02:38 ET | 3400 | 0.6307 |
02:40 ET | 792 | 0.6332 |
02:42 ET | 200 | 0.6332 |
02:49 ET | 215 | 0.64 |
03:03 ET | 1300 | 0.6336 |
03:05 ET | 2201 | 0.634 |
03:16 ET | 12994 | 0.63 |
03:27 ET | 1000 | 0.6316 |
03:30 ET | 680 | 0.6328 |
03:34 ET | 100 | 0.6316 |
03:38 ET | 400 | 0.632799 |
03:41 ET | 954 | 0.63155 |
03:45 ET | 670 | 0.6316 |
03:54 ET | 300 | 0.6316 |
03:56 ET | 792 | 0.6324 |
03:57 ET | 600 | 0.6328 |
03:59 ET | 17772 | 0.64 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
BioLine RX Ltd | 55.9M | -0.8x | --- |
Cue Biopharma Inc | 66.2M | -1.3x | --- |
Dyadic International Inc | 60.8M | -7.2x | --- |
Lipocine Inc | 50.8M | -6.3x | --- |
LAVA Therapeutics NV | 61.5M | -2.0x | --- |
Kronos Bio Inc | 64.9M | -0.5x | --- |
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $55.9M |
---|---|
Revenue (TTM) | $11.7M |
Shares Outstanding | 79.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.54 |
EPS | $-0.76 |
Book Value | $0.18 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | 4.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -391.76% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.